CDC INVEST: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CDC INVEST
Largest movements
- Cash +€138,972
up €138,972 (+81270.4%), from €171 to €139,143
mainly Receivables within one year (+€112,764) and Net result for the year (+€54,085)
- Receivables within one year -€112,764
down €112,764 (-73.3%), from €153,880 to €41,117
of which Other amounts receivable: -€112,364
- Reserves +€54,085
up €54,085 (+137.3%), from €39,387 to €93,472
- Other debts -€27,049
down €27,049 (-28.7%), from €94,371 to €67,322
- Gross operating margin +€22,628
up €22,628 (+61.4%), from €36,870 to €59,497
- Financial charges -€2,414
down €2,414 (-39.6%), from €6,097 to €3,683
- Financial income +€1,153
up €1,153 (+869.8%), from €133 to €1,286
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €154,051 | €180,472 | +€26,421 | +17.2% |
| Current assets | 29/58 | €154,051 | €180,472 | +€26,421 | +17.2% |
| Amounts receivable within one year | 40/41 | €153,880 | €41,117 | -€112,764 | -73.3% |
| Trade receivables | 40 | €750 | €350 | -€400 | -53.3% |
| Other amounts receivable | 41 | €153,130 | €40,767 | -€112,364 | -73.4% |
| Cash at bank and in hand | 54/58 | €171 | €139,143 | +€138,972 | +81270.4% |
| Deferred charges and accrued income | 490/1 | - | €212 | +€212 | |
| Total equity and liabilities | 10/49 | €154,051 | €180,472 | +€26,421 | +17.2% |
| Equity | 10/15 | €57,987 | €112,072 | +€54,085 | +93.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €39,387 | €93,472 | +€54,085 | +137.3% |
| Distributable reserves | 133 | €39,387 | €93,472 | +€54,085 | +137.3% |
| Amounts payable | 17/49 | €96,064 | €68,400 | -€27,664 | -28.8% |
| Amounts payable within one year | 42/48 | €96,064 | €68,400 | -€27,664 | -28.8% |
| Trade debts | 44 | €212 | €572 | +€360 | +169.6% |
| Suppliers | 440/4 | €212 | €572 | +€360 | +169.6% |
| Advances received on contracts in progress | 46 | €908 | €0 | -€908 | -100.0% |
| Taxes, remuneration and social security | 45 | €574 | €506 | -€68 | -11.8% |
| Taxes | 450/3 | €574 | €506 | -€68 | -11.8% |
| Other amounts payable | 47/48 | €94,371 | €67,322 | -€27,049 | -28.7% |
| Other operating charges | 640/8 | €615 | €635 | +€20 | +3.2% |
| Non-recurring operating charges | 66A | - | €2,380 | +€2,380 | |
| Gross operating margin | 9900 | €36,870 | €59,497 | +€22,628 | +61.4% |
| Operating profit (loss) | 9901 | €36,254 | €56,482 | +€20,228 | +55.8% |
| Financial income | 75/76B | €133 | €1,286 | +€1,153 | +869.8% |
| Recurring financial income | 75 | €133 | €1,286 | +€1,153 | +869.8% |
| Financial charges | 65/66B | €6,097 | €3,683 | -€2,414 | -39.6% |
| Recurring financial charges | 65 | €6,097 | €3,683 | -€2,414 | -39.6% |
| Profit (loss) for the period before taxes | 9903 | €30,290 | €54,085 | +€23,796 | +78.6% |
| Profit (loss) for the period | 9904 | €30,290 | €54,085 | +€23,796 | +78.6% |
| Profit (loss) for the period to be appropriated | 9905 | €30,290 | €54,085 | +€23,796 | +78.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.